Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 18.

How rotavirus infection accelerates autoimmune diabetes in a mouse model
A combination of genetic predisposition and environmental factors is believed to cause autoimmune (type 1) diabetes. A new study gets at the mechanisms by which rotavirus infection contributes to autoimmune diabetes in a mouse model of the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 28, 2014 Category: Science Source Type: news

How rotavirus infection accelerates autoimmune diabetes in a mouse model
(PLOS) A combination of genetic predisposition and environmental factors is believed to cause autoimmune (type 1) diabetes. A study published on March 27 in PLOS Pathogens gets at the mechanisms by which rotavirus infection contributes to autoimmune diabetes in a mouse model of the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 27, 2014 Category: Infectious Diseases Source Type: news

Multiple sclerosis patients may benefit from statins, says study
This study suggests, however, that the beneficial effect might be on vascular function rather than the immune system, he added. "After nearly two decades of research, it is immensely gratifying to see this work progress into the clinic to deliver benefits to patients," he said.MS is an autoimmune disease in which myelin, the fatty insulating material that covers nerve fibres, is destroyed by the body's own defences. Nerves lacking myelin are not able to transmit messages properly, leading to symptoms ranging from mild tingling or numbness to full blown paralysis.Dr Susan Kohlhaas, head of biomedical research at the MS Soci...
Source: Guardian Unlimited Science - March 19, 2014 Category: Science Authors: Sarah Boseley Tags: The Guardian Pharmaceuticals industry News UCL (University College London) Health Medical research Society Drugs Multiple sclerosis UK news Science Source Type: news

Statins may slow progression of MS
ConclusionThis was an early stage, phase II trial, which found that simvastatin reduced the rate of brain shrinkage in patients in the later stages of MS. The results are promising and warrant a larger phase III trial, examining whether the drug could slow the disease in patients at this stage of MS.  It should be noted that although simvastatin had some effect on outcomes in one disability scale and one symptom scale, the trial was primarily aimed at measuring the effect on brain shrinkage, rather than patients’ symptoms.To conclude, it is unclear what effect simvastatin, if any, would have on long-term quality of life...
Source: NHS News Feed - March 19, 2014 Category: Consumer Health News Tags: Medication Neurology Source Type: news

What are expectations that can come from the Accelerating Medicines Partnership?
Virginia Ladd - AMP Submitted by Julie on Mon, 03/17/2014 - 12:45 Autoimmune diseases affect 50 million Americans and are a leading cause of death and disability — yet we have no cure. Historically, the first goal of treatment is to reduce inflammation focusing on making quality of life as good as possible. However, more needs to be done on greater research options for all autoimmune disease-related patients. Share Email Print var switchTo5x = false;var __st_loadLate = true;stLight.options({"publisher":"dr-e0d16a36-b72f-d979-d8a1-314a351971a6...
Source: PHRMA - March 17, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news

Leslie Hanrahan - AMP
We believe this initiative will ultimately lead to new understanding of the underlying causes of lupus along with new therapies for this disease and ultimately an improved quality of life for people living with lupus. For us it is all about the patient! Lupus is  complex and is arguably the most clinically diverse of all autoimmune diseases. Because of this, the scope of the Accelerating Medicines Partnership (AMP)  is tailor made for a collaborative effort among the NIH, industry, academic medical research centers and non profit organization. Lupus was selected for this project because of the lack of effective targeted ...
Source: PHRMA - March 17, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news

James Sullivan - AMP
It's often said that baseball players have to generate 4 hits out of every 10 at-bats to be considered a Hall of Fame-caliber player.  Meteorologists are criticized for inaccurate forecasts more often than not.  But think about the drug development business: only one in every 5,000 to 10,000 compounds in drug discovery will make it through regulatory approval and even treatments that reach clinical trials only have a 16% chance of approval. (Source: Tufts Center for the Study of Drug Development. "Large Pharma Success Rate for Drugs Entering Clinical Trials in 1993-2004: 16%." Impact Report 2009; innovation.org) What if ...
Source: PHRMA - March 17, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news

Virginia Ladd - AMP
Autoimmune diseases affect 50 million Americans and are a leading cause of death and disability — yet we have no cure. Historically, the first goal of treatment is to reduce inflammation focusing on making quality of life as good as possible. However, more needs to be done on greater research options for all autoimmune disease-related patients. In existing research, 80-100 different autoimmune diseases have been identified and researchers suspect at least 40 additional diseases of having an autoimmune basis. These diseases are chronic and can be life-threatening. The American Autoimmune Related Diseases Association (AARD...
Source: PHRMA - March 17, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news

Sanofi And UCB To Discover And Develop AutoImmune Drugs
Sanofi and UCB have entered into a strategic and scientific partnership to try to discover and develop novel anti-inflammatory small molecules for potential treatment of a broad range of immune-mediated diseases. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - March 12, 2014 Category: Pharmaceuticals Source Type: news

Organ transplant approach might end lifelong drug treatment
Organ-transplant recipients often reject donated organs, but a new, two-pronged strategy developed by UC San Francisco researchers to specifically weaken immune responses that target transplanted tissue has shown promise in controlled experiments on mice.The hope is that using this novel treatment strategy at the time of transplantation surgery could spare patients from lifelong immunosuppressive treatments and their side effects. The approach might also be used to treat autoimmune diseases such as type 1 diabetes, the researchers said. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 12, 2014 Category: Consumer Health News Tags: Transplants / Organ Donations Source Type: news

B-cells aggravate autoimmune diseases
This study offers an additional explanation to how B-cells regulate an immune response.In Germany, approximately 800,000 people suffer from rheumatoid arthritis. In this progressive disease, a person's own immune system attacks and destroys connective tissue. However, the most important factors governing the progress of the disease are still unknown. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 10, 2014 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Autoimmune diseases can be cured naturally
(Source: NaturalNews.com)
Source: NaturalNews.com - March 6, 2014 Category: Consumer Health News Source Type: news

B-cells aggravate autoimmune diseases
This study offers an additional explanation to how B-cells regulate an immune response. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 5, 2014 Category: Science Source Type: news

B-cells aggravate autoimmune diseases
(Max-Planck-Gesellschaft) Antibody producers regulate the immune response using a recently discovered mechanism. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 5, 2014 Category: Global & Universal Source Type: news

“Autoimmune Disease Treatment,” a New Article on Vkool.Com, Teaches...
The new “Autoimmune Disease Treatment” writing on the website Vkool.com covers natural ways to treat autoimmune diseases effectively.(PRWeb February 26, 2014)Read the full story at http://www.prweb.com/releases/autoimmune-disease/treatment/prweb11613961.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 27, 2014 Category: Pharmaceuticals Source Type: news

What are some realistic expectations that can come from the Accelerating Medicines Partnership?
Opinionconversations48254827Autoimmune diseases affect 50 million Americans and are a leading cause of death and disability — yet we have no cure. Historically, the first goal of treatment is to reduce inflammation focusing on making quality of life as good as possible. However, more needs to be done on greater research options for all autoimmune disease-related patients. In existing research, 80-100 different autoimmune diseases have been identified and researchers suspect at least 40 additional diseases of having an autoimmune basis. These diseases are chronic and can be life-threatening. The American Autoimmune Relate...
Source: PHRMA - February 26, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news

Virginia T. Ladd
President & Executive Director, American Autoimmune Related Diseases Association, Inc. Virginia T. Ladd, R.T. – Virginia Ladd is the President and Executive Director of the American Autoimmune Related Diseases Association, Inc. (AARDA), an organization that she founded to bring a national focus to autoimmunity and increase collaboration in autoimmune research, education, awareness, and advocacy. She has been involved in the nonprofit community for over 30 years as a patient advocate and educator. Mrs. Ladd served as president and executive director of the Lupus Foundation of America. Mrs. Ladd was instrumental in the...
Source: PHRMA - February 26, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news

Schizophrenics at greater risk of getting diseases
People suffering from schizophrenia have an increased risk of contracting autoimmune diseases, especially if they have suffered from a severe infection, new research based on data sets covering the majority of the Danish population shows. With the aid of these large data sets, the researchers have been able to show certain correlations with great statistical certainty, but the study does not provide a definitive explanation for why schizophrenics have such an increased risk of contracting these diseases, except to suggest that lifestyle, genetics and the disease itself may contribute to the complicated situation. (Source: ...
Source: ScienceDaily Headlines - February 21, 2014 Category: Science Source Type: news

Schizophrenics are at greater risk of getting diseases
(Aarhus University) New research based on data sets covering the majority of the Danish population shows that people suffering from schizophrenia have an increased risk of contracting autoimmune diseases, especially if they have suffered from a severe infection. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 21, 2014 Category: Biology Source Type: news

A Brain on Fire
In 2009, a young New York Post reporter contracted a brain infection and learned what it means to be alive, conscious, and not present in your own body. She also learned an important lesson about modern medical care.read more (Source: Psychology Today Personality Center)
Source: Psychology Today Personality Center - February 18, 2014 Category: Psychiatry & Psychology Authors: Denise Cummins, Ph.D. Tags: Neuroscience Personality Philosophy Resilience autoimmune diseases brain on fire insanity new york post reporter nmda susannah cahalan Source Type: news

A Medical Mystery, a Reporter, and a Month of Madness
In 2009, a young New York Post reporter contracted a brain infection and learned what it means to be alive, conscious, and not present in your own body. She also learned an important lesson about modern medical care.read more (Source: Psychology Today Personality Center)
Source: Psychology Today Personality Center - February 18, 2014 Category: Psychiatry & Psychology Authors: Denise Cummins, Ph.D. Tags: Neuroscience Personality Philosophy Resilience autoimmune diseases brain on fire insanity new york post reporter nmda susannah cahalan Source Type: news

What are our greatest challenges as we address managing chronic diseases like diabetes?
conversationsphrmapediaOpinion480448091404Despite many attempts by prominent researchers utilizing different approaches, there is no cure for diabetes. While continuing extensive research looking into “the cure”, much work is being conducted in the day –to- day management of diabetes. As such, it is essential to develop treatments that not only help measure and adjust blood glucose levels- thus preventing hyper and hypoglycemia, but also to improve the quality of life in our patients with diabetes. The amount of self care skills required to manage diabetes is extensive, requiring blood glucose monitoring, insulin inj...
Source: PHRMA - February 11, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news

Quantibody Arrays for Tracking Patient Health
Neuromics is working with Dr. Joe Smarda, a renowned Immunologist, to track levels of cytokines in the blood serum of his clients. We have selected RayBiotech's Quantibody® Arrays for these assays. The Clinics in Joe's network treat his clients for autoimmune related disorders.Our regime is:Test clients pre-treatmentTreatTestRefine treatmentTest The specified treatment regime is continued until clients have blood serum cytokine levels that are in the range of our healthy controls. Here's data from our Quantibody® T-helper cell Cytokine Arrays (pre-treatment).Figures IL-6, IL-1 beta, MCP-1 and PAI1 Array results...
Source: Neuromics - February 10, 2014 Category: Neuroscience Tags: autoimmune disease. Rheumatoid Arthritis immune response inflammatory response Quantibody Arrays Raybiotech Source Type: news

Bifunctional Antibody Fragment-Based Fusion Proteins for the Targeted Elimination of Pathogenic T-Cell Subsets
Pathogenic effector T cells are key contributors to autoimmune diseases such as systemic lupus erythematosus (SLE). General inhibition of T cells using, e.g., methotrexate, prednisolone, or TNF blockers, has prominent therapeutic effects frequently at the cost of severe long-term side effects and toxicity. Therefore, targeted strategies that can selectively inhibit or eliminate pathogenic T cells are sought after as a new approach to safely block perpetual inflammatory T-cell responses and inhibit concomitant progressive tissue destruction. Of particular interest in this respect is the use of the so-called single-chain fra...
Source: Springer protocols feed by Immunology - February 7, 2014 Category: Allergy & Immunology Source Type: news

Measurement of Malondialdehyde, Glutathione, and Glutathione Peroxidase in SLE Patients
Oxidative stress contributes to chronic inflammation of tissues and plays a central role in immunomodulation, which may lead to autoimmune diseases such as systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Markers of oxidative damage include malondialdehyde (MDA), antioxidant scavengers as glutathione (GSH), and glutathione peroxidase (GSH Px), which all correlate well with SLE disease activity. Amelioration of some clinical manifestations of SLE may be expected by targeting lipid peroxidation with dietary or pharmacological antioxidants. (Source: Springer protocols feed by Immunology)
Source: Springer protocols feed by Immunology - February 7, 2014 Category: Allergy & Immunology Source Type: news

Generation of Self-Peptides to Treat Systemic Lupus Erythematosus
Synthetic peptides are attracting increasing attention as therapeutics. Despite their potential, however, only a few selected peptides have been able to enter in clinical trials for chronic autoimmune diseases and systemic lupus erythematosus (SLE) in particular. Here, we describe and discuss a series of assays, which may help in characterizing valuable candidate peptides that were applied in our laboratory to develop the lupus P140 peptide program. The different steps of selection include the choice of the initial autoantigen, the design, synthesis and purification of peptides, their preliminary screen by measuring cytoki...
Source: Springer protocols feed by Immunology - February 7, 2014 Category: Allergy & Immunology Source Type: news

Detection of SLE Antigens in Neutrophil Extracellular Traps (NETs)
Neutrophils are sentinel cells of the innate immune system with a primary role of clearing extracellular pathogens. The release of weblike structures decorated with granular proteins called neutrophil extracellular traps (NETs) has recently been implicated in the pathogenesis of inflammatory and autoimmune diseases. Indeed, NETs may represent an important source of autoantigens and immunostimulatory proteins in systemic lupus erythematosus (SLE). In this chapter, we describe protocols to isolate human peripheral neutrophils, to generate and isolate NETs, and to detect SLE antigens in NETs using immunofluorescence and immun...
Source: Springer protocols feed by Immunology - February 7, 2014 Category: Allergy & Immunology Source Type: news

Microarray Technology for Analysis of MicroRNA Expression in Renal Biopsies of Lupus Nephritis Patients
This article offers a technological overview of microarray technology for analysis of microRNA gene expression in kidney biopsies from SLE patients. (Source: Springer protocols feed by Immunology)
Source: Springer protocols feed by Immunology - February 7, 2014 Category: Allergy & Immunology Source Type: news

Laboratory Tests for the Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent vascular thrombosis (VT) and/or pregnancy morbidity (PM) in the presence of persistent antiphospholipid antibodies (aPL), detected by lupus anticoagulant (LA), anticardiolipin (aCL) antibody, and/or anti‐β2 glycoprotein I (aβ2GPI) antibody assays. These aPL, considered to be diagnostic markers and pathogenic drivers of APS, are a heterogeneous group of antibodies directed against anionic phospholipids, phospholipid-binding plasma proteins, and phospholipid–protein complexes. Although APS is currently considered as a s...
Source: Springer protocols feed by Immunology - February 7, 2014 Category: Allergy & Immunology Source Type: news

Evaluating a Particular Circulating MicroRNA Species from an SLE Patient Using Stem-Loop qRT-PCR
Systemic lupus erythematosus (SLE) is a complex autoimmune disease, and correct judgment of SLE activity is very important in guiding precise clinical treatment. Circulating microRNAs (miRNAs) could serve as potential biomarkers of disease activity or status in SLE, and here we describe a modified qRT-PCR method for detecting them. Stem loop has become one of the most powerful methods for determining miRNA expression because it is highly sensitive and accurate and requires only small amount of sample. In this chapter, we focus on a stem-loop reverse transcription-bound SYBR green qRT-PCR protocol for evaluating a particula...
Source: Springer protocols feed by Immunology - February 7, 2014 Category: Allergy & Immunology Source Type: news

Pathology of Systemic Lupus Erythematosus: The Challenges Ahead
Many studies have explored the pathology of systemic lupus erythematosus (SLE), an autoimmune rheumatic disorder with a striking female predominance. Numerous autoimmune phenomena are present in this disease, which ultimately result in organ damage. However, the specific cellular and humoral mechanisms underlying the immune dysfunction are not yet fully understood. (Source: Springer protocols feed by Immunology)
Source: Springer protocols feed by Immunology - February 7, 2014 Category: Allergy & Immunology Source Type: news

Recombinant Antibody Microarray for Profiling the Serum Proteome of SLE
Systemic lupus erythematosus (SLE) is a severe autoimmune connective tissue disease. Our current knowledge about the serum proteome, or serum biomarker panels, reflecting disease and disease status is still very limited. Affinity proteomics, represented by recombinant antibody arrays, is a novel, multiplex technology for high-throughput protein expression profiling of crude serum proteomes in a highly specific, sensitive, and miniaturized manner. The antibodies are deposited one by one in an ordered pattern, an array, onto a solid support. Next, the sample is added, and any specifically bound proteins are detected and quan...
Source: Springer protocols feed by Immunology - February 7, 2014 Category: Allergy & Immunology Source Type: news

NIH, industry and non-profits join forces to speed validation of disease targets
Goal is to develop new treatments earlier, beginning with Alzheimer's, type 2 diabetes, and autoimmune disorders. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 4, 2014 Category: American Health Source Type: news

Stem cell agency's grants to UCLA help set stage for revolutionary medicine
Scientists from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research were today awarded grants totaling more than $3.5 million by California's stem cell agency for their ongoing efforts to advance revolutionary stem cell science in medicine.   Recipients of the awards from the California Institute of Regenerative Medicine (CIRM) included Lili Yang ($614,400), who researches how stem cells become rare immune cells; Denis Evseenko ($1,146,468), who is studying the biological niche in which stem cells grow into cartilage; Thomas Otis and Bennet Novitch ($1,148,758), who are using new techni...
Source: UCLA Newsroom: Health Sciences - January 29, 2014 Category: Universities & Medical Training Source Type: news

Hanover Portfolio Acquisitions Changes Its Name to Endonovo Therapeutics
Endonovo Therapeutics, Inc. Is Developing Non-Invasive Treatments for Various Inflammatory, Autoimmune and Degenerative Diseases Using Time-Varying Electromagnetic Fields LOS ANGELES, CA--(Healthcare Sales & Marketing Network) - Hanover Portfolio Acquis... Devices, Regenerative MedicineEndonovo Therapeutics, Time-Varying Electromagnetic Field (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 28, 2014 Category: Pharmaceuticals Source Type: news

Clinical Research Manager – EMD Serono, Billerica, USA
Added via Nature Jobs. EMD Serono, the biopharmaceutical division of Merck KGaA is seeking a Clinical Research Manager to work on therapeutic areas of neurodegenerative diseases, fertility and metabolic endocrinology, as well as oncology and autoimmune/inflammatory diseases. The successful applicant will write scientific rationale for clinical trial protocols, develop clinical development plans and liaise with external experts to accumulate scientific and medical knowledge to support these plans. The deadline for applications is 6 March 2014. For more information, please visit the job advert. (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 22, 2014 Category: Endocrinology Source Type: news

Mesothelioma Stem Cell Research at PMC Holds Great Potential
The Pacific Heart, Lung & Blood Institute in California is moving forward with potentially groundbreaking stem cell mesothelioma research that could dramatically change the treatment of this disease. While mesenchymal stem cells already are utilized in therapies for several autoimmune diseases, the novel research will explore using them for the first time as a vehicle to deliver molecular and gene therapies directly to mesothelioma sites. The goal is to develop a reliable therapy to provide consistent, long-term survival for pleural mesothelioma patients, which currently doesn't exist. The majority of meso...
Source: Asbestos and Mesothelioma News - January 16, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Research & Clinical Trials Source Type: news

Army medic exposed to uranium in race to raise £25,000 for treatment
Katrina Brown, 31, from Gloucestershire, developed a potentially fatal autoimmune disease after exposure to depleted uranium. She has just weeks left to raise funds. (Source: the Mail online | Health)
Source: the Mail online | Health - January 15, 2014 Category: Consumer Health News Source Type: news

When Germs Attack: A Lens into the Molecular Dance - 1/7/14
Researchers at Johns Hopkins have zoomed in on what is going on at the molecular level when the body recognizes and defends against an attack of pathogens, and the findings, they say, could influence how drugs are developed to treat autoimmune diseases. (Source: Johns Hopkins Medicine News)
Source: Johns Hopkins Medicine News - January 7, 2014 Category: Research Source Type: news

Chronic Urticaria and AutoimmunityChronic Urticaria and Autoimmunity
Over 50% of cases of chronic urticaria are thought to result from an autoimmune mechanism, and association has been found with thyroid disease, RA, and more. What are the therapeutic implications? Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 3, 2014 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

How To Build Your Immune System: Diet and Exercise
Many people are familiar with the words, ‘immune system,’ but what do these words actually mean? (Source: Disabled World)
Source: Disabled World - December 29, 2013 Category: Disability Tags: Autoimmune Diseases Source Type: news

Bone marrow mesenchymal stem cells isolated from multiple sclerosis patients have decreased suppressive function
Multiple sclerosis (MS), an inflammatory autoimmune disease affecting more than one million people worldwide, is caused by an immune reaction to myelin proteins, the proteins that help form the myelin insulating substance around nerves. Demyelination and MS are a consequence of this immune reaction. Bone marrow mesenchymal stem cells (MSCs) have been considered as an important source for cell therapy for autoimmune diseases such as MS because of their immunosuppressive properties. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 28, 2013 Category: Consumer Health News Tags: Multiple Sclerosis Source Type: news

'Oldest case of sarcoidosis' uncovered in French Revolution leader
Maximilien de Robespierre was one of the most influential and best known figures in the French Revolution. A lawyer and politician who was guillotined in 1794, he might also have been the first described case of the rare immune disorder sarcoidosis.The first case of the disease had been published over 100 years after the subject of this latest discovery, in 1877 by a pioneer in the understanding of the autoimmune disorder, Sir Jonathan Hutchinson. He described a 58-year-old coal-wharf worker with purple, symmetrical skin plaques on the legs and hands. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 27, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

B cells may be activated in autoimmunity by newly identified immune receptor
A newly identified immune protein influences each person's response to vaccines and risk for autoimmune diseases like lupus and multiple sclerosis, according to a study published by researchers from the School of Medicine at the University of Alabama at Birmingham in the journal Science Translational Medicine. The protein, called a receptor and part of signaling pathways, also provides a new target for personalized therapies for patients with autoimmune diseases. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 24, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news

Study confirms narcolepsy as an autoimmune disease
A new study that offers some of the most compelling evidence to date for the idea of "mimicry," where the immune system attacks a body protein because of its similarity to a pathogen protein, confirms that narcolepsy is an autoimmune disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 20, 2013 Category: Consumer Health News Tags: Sleep / Sleep Disorders / Insomnia Source Type: news

Common disorders: It's not the genes themselves, but how they are controlled
(Case Western Reserve University) Many rare disorders are caused by gene mutation. Yet until now the underlying genetic cause of more common conditions has evaded scientists for years. New research from Case Western Reserve University to appear in Genome Research finds that six common diseases arise from DNA changes located outside genes. The study from the laboratory of Peter Scacheri, PhD, shows that multiple DNA changes, or variants, work in concert to affect genes, leading to autoimmune diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 20, 2013 Category: Global & Universal Source Type: news

Incurable autoimmune disorders can be treated successfully with functional medicine
Autoimmune disorders are defined as conditions in which the immune system mistakenly attacks healthy tissue. There are more than 80 types of auto-immune disorders including multiple sclerosis (MS), rheumatoid arthritis, type I diabetes, lupus and inflammatory bowel disease... (Source: NaturalNews.com)
Source: NaturalNews.com - December 19, 2013 Category: Consumer Health News Source Type: news

New Insights into Sleeping Disorder Narcolepsy
It may have its roots in immune system problems, study suggests Source: HealthDay Related MedlinePlus Pages: Autoimmune Diseases, H1N1 Flu (Swine Flu), Sleep Disorders (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 18, 2013 Category: Consumer Health News Source Type: news

Preferable treatment for MS found in allogenic bone marrow stem cells
(Cell Transplantation Center of Excellence for Aging and Brain Repair) Multiple sclerosis (MS) is caused by an immune reaction to myelin proteins that form the myelin insulating substance around nerves, resulting in demyelination. Bone marrow mesenchymal stem cells (MSCs) have been considered as an important source for cell therapy for autoimmune diseases such as MS because of their immunosuppressive properties. Researchers compared MSCs isolated from MS patients and from healthy donors to determine if the MSCs from MS patients are immunosuppressively normal or defective. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 18, 2013 Category: Global & Universal Source Type: news

Woman shrinks thyroid nodules with pure nutrition, not meds
I have Hashimoto's thyroiditis. I manage it completely naturally, and my thyroid is producing the proper amounts of T3 and T4 thyroid hormones on its own, without medication. However, since this is an autoimmune disease, the thyroid antibodies produced cause the immune... (Source: NaturalNews.com)
Source: NaturalNews.com - December 17, 2013 Category: Consumer Health News Source Type: news